ClariVest Asset Management’s Tectonic Therapeutic TECX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q2
Sell
-1,933
Closed -$294K 837
2021
Q1
$294K Buy
1,933
+100
+5% +$16.3K 0.01% 462
2020
Q4
$307K Sell
1,833
-17
-0.9% -$3.02K 0.01% 460
2020
Q3
$289K Buy
1,850
+233
+14% +$46.9K 0.01% 420
2020
Q2
$338K Buy
+1,617
New +$333K 0.01% 464

Other funds holding TECX

ClariVest Asset Management's TECX Position: Q2 2021 in Review

ClariVest Asset Management sold out of Tectonic Therapeutic (TECX) in Q2 2021, closing a stake of 1,933 shares — an estimated $294K sold.

ClariVest Asset Management first reported a position in TECX in Q2 2020 and held it in 4 quarters. The position peaked at $338K in Q2 2020. 97 funds tracked by Wall St. Rank hold TECX as of Q2 2021.

  • ClariVest Asset Management reported no remaining Tectonic Therapeutic position as of Q2 2021 after selling out during the quarter.
  • ClariVest Asset Management sold 1,933 Tectonic Therapeutic shares in Q2 2021, an estimated $294K.
  • ClariVest Asset Management first reported a position in Tectonic Therapeutic in Q2 2020 and held it in 4 quarters.
  • ClariVest Asset Management's Tectonic Therapeutic position peaked at $338K in Q2 2020.
  • 97 funds tracked by Wall St. Rank held Tectonic Therapeutic as of Q2 2021.

Based on ClariVest Asset Management's 13F filing for Q2 2021, filed 9 Aug 2021.